
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engi... Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.62 | 1.9 | 1.41 | 2912856 | 1.68050772 | CS |
4 | -0.94 | -36.71875 | 2.56 | 2.665 | 1.33 | 2835671 | 2.01054194 | CS |
12 | -0.87 | -34.9397590361 | 2.49 | 4.08 | 1.33 | 1709116 | 2.45688527 | CS |
26 | -0.1 | -5.81395348837 | 1.72 | 4.08 | 1.27 | 1319856 | 2.19638473 | CS |
52 | 0.07 | 4.51612903226 | 1.55 | 4.08 | 0.765 | 839130 | 2.01358135 | CS |
156 | 0.14 | 9.45945945946 | 1.48 | 5.65 | 0.765 | 503469 | 2.3174124 | CS |
260 | -2.48 | -60.487804878 | 4.1 | 5.65 | 0.765 | 437718 | 2.3348162 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관